| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.6 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.11 | 0.6 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.11 | 0.6 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |